Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Dafalgan Capsules*


Generally acceptable

May be acceptable
Risk of skin rash in breastfed infant
Dafalgan Capsules* :
Type Medicine Non Marketed
Originator B
Agent Pacific Pharma
Distributor Pacific Pharma
Laboratory UPSA
Responsible Party UPSA
Origin France
Manufacturer UPSA SAS
Origin France
ATC N02BE01

Your comment will appear shortly after approval

Dafalgan Capsules* :

Revision Date : 30/11/2015


Effect Frequency
Anaphylactic shock Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Hypersensitivity reactions Rare
Leucopenia (Leukopenia) Very rare
Neutropenia aggravated Very rare
Skin rash Rare
Thrombocytopenia (Thrombopenia) Very rare
Urticaria Rare

Different Units By MoH Code

Dafalgan Capsules*  MoH 191 :
Form Capsule, hard
Package Size Box of 16
Strength 500mg
NSSF ✘
Quarantine ✘
Reg. Number 27723
Submission date 01/01/1994
Registration Year 1994
Archived Date 2014


Price Comparison

● Country: Switzerland
● Package Size: 16
● Public Price: 2.45 CHF ( 253,379.00 LBP )
● Pack size unit used: 16
● Cost/Unit: 0,1531 CHF ( 0.00 LBP )
● Exfactory Price: 1.33 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 16
● Public Price: 2.09 EUR ( 202,470.84 LBP )
● Pack size unit used: 16
● Cost/Unit: 0,1306 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info